Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Net Income (2016 - 2025)

Historic Net Income for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$6.4 million.

  • Angiodynamics' Net Income rose 4086.42% to -$6.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$27.7 million, marking a year-over-year increase of 8766.92%. This contributed to the annual value of -$34.0 million for FY2025, which is 8156.05% up from last year.
  • Angiodynamics' Net Income amounted to -$6.4 million in Q4 2025, which was up 4086.42% from -$10.9 million recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Net Income peaked at $45.9 million during Q3 2023, and registered a low of -$187.7 million during Q1 2024.
  • Moreover, its 5-year median value for Net Income was -$9.0 million (2022), whereas its average is -$16.9 million.
  • As far as peak fluctuations go, Angiodynamics' Net Income surged by 45284.53% in 2023, and later plummeted by 187929.36% in 2024.
  • Angiodynamics' Net Income (Quarter) stood at -$8.4 million in 2021, then decreased by 1.62% to -$8.5 million in 2022, then crashed by 242.3% to -$29.0 million in 2023, then surged by 63.03% to -$10.7 million in 2024, then skyrocketed by 40.86% to -$6.4 million in 2025.
  • Its Net Income stands at -$6.4 million for Q4 2025, versus -$10.9 million for Q3 2025 and -$6.0 million for Q2 2025.